Page last updated: 2024-09-04

docetaxel anhydrous and noscapine

docetaxel anhydrous has been researched along with noscapine in 3 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(noscapine)
Trials
(noscapine)
Recent Studies (post-2010) (noscapine)
12,1103,2166,92051016191

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)noscapine (IC50)
Solute carrier family 22 member 2Homo sapiens (human)2.6
Cytochrome P450 2C9 Homo sapiens (human)8.1773
Cytochrome P450 2C19Homo sapiens (human)0.4003

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capuano, B; DeBono, A; Scammells, PJ1
Chowdhury, N; Doddapaneni, R; Patel, K; Singh, M2

Other Studies

3 other study(ies) available for docetaxel anhydrous and noscapine

ArticleYear
Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents.
    Journal of medicinal chemistry, 2015, Aug-13, Volume: 58, Issue:15

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Neoplasms; Noscapine

2015
Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
    Experimental cell research, 2016, 08-01, Volume: 346, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Coumarins; Docetaxel; Drug Carriers; Enzyme Activation; Fluorescent Antibody Technique; Humans; JNK Mitogen-Activated Protein Kinases; Liposomes; Mice; Microtubules; Nanoparticles; Noscapine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polymerization; Staining and Labeling; Taxoids; Thiazoles; Triple Negative Breast Neoplasms; Tubulin; Xenograft Model Antitumor Assays

2016
Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.
    Scientific reports, 2017, Nov-20, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Liposomes; Mice; Noscapine; Taxoids; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2017